Improving cancer immunotherapy with DNA methyltransferase inhibitors.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 7, p. 787, doi. 10.1007/s00262-015-1776-3
- By:
- Publication type:
- Article
Works matching IS 03407004 AND DT 2016 AND VI 65 AND IP 7
Results: 12
1
2
PD-L1-specific T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 7, p. 797, doi. 10.1007/s00262-015-1783-4
- By:
- Publication type:
- Article
3
Redefining cancer immunotherapy-optimization, personalization, and new predictive biomarkers: 4th Cancer Immunotherapy and Immunomonitoring (CITIM) meeting, April 27-30, 2015, Ljubljana, Slovenia.
- Published in:
- 2016
- By:
- Publication type:
- Report
4
Lessons learned from cancer vaccine trials and target antigen choice.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 7, p. 805, doi. 10.1007/s00262-016-1801-1
- By:
- Publication type:
- Article
5
High immunosuppressive burden in cancer patients: a major hurdle for cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 7, p. 813, doi. 10.1007/s00262-016-1810-0
- By:
- Publication type:
- Article
6
Tumor-derived factors modulating dendritic cell function.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 7, p. 821, doi. 10.1007/s00262-016-1820-y
- By:
- Publication type:
- Article
7
Adoptive transfer of osteoclast-expanded natural killer cells for immunotherapy targeting cancer stem-like cells in humanized mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 7, p. 835, doi. 10.1007/s00262-016-1822-9
- By:
- Publication type:
- Article
8
Immunobiology and immunosurveillance in patients with intraductal papillary mucinous neoplasms (IPMNs), premalignant precursors of pancreatic adenocarcinomas.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 7, p. 771, doi. 10.1007/s00262-016-1838-1
- By:
- Publication type:
- Article
9
How frequently are predicted peptides actually recognized by CD8 cells?
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 7, p. 847, doi. 10.1007/s00262-016-1840-7
- By:
- Publication type:
- Article
10
Myeloid-derived suppressor cells as intruders and targets: clinical implications in cancer therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 7, p. 857, doi. 10.1007/s00262-016-1849-y
- By:
- Publication type:
- Article
11
Uncoupling protein 2 regulates metabolic reprogramming and fate of antigen-stimulated CD8+ T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 7, p. 869, doi. 10.1007/s00262-016-1851-4
- By:
- Publication type:
- Article
12
Immune-modulating properties of ionizing radiation: rationale for the treatment of cancer by combination radiotherapy and immune checkpoint inhibitors.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 7, p. 779, doi. 10.1007/s00262-015-1771-8
- By:
- Publication type:
- Article